Automatic digital analysis of chromogenic media for vancomycin-resistant-enterococcus screens using Copan WASPLab

Journal of Clinical Microbiology

Volumn 54, Issue 10, 2016, Pages 2464-2469

  Faron, Matthew L ^a   Buchan, Blake W ^a,b   Coon, Christopher ^a   Liebregts, Theo ^c   Van Bree, Anita ^c   Jansz, Arjan R ^c   Soucy, Genevieve ^d   Korver, John ^e   Ledeboer, Nathan A ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Diagnostic Laboratories   (United States)

^c Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

^d LAVAL UNIVERSITY   (Canada)

^e HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; AUTOMATIC DIGITAL ANALYSIS; AUTOMATION; BACTERIUM IDENTIFICATION; COLORIMETRY; COST CONTROL; DIGITAL IMAGING; IMAGE ANALYSIS; IMAGE PROCESSING; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOFTWARE; VANCOMYCIN RESISTANT ENTEROCOCCUS; CHEMISTRY; COMPARATIVE STUDY; CULTURE MEDIUM; DIAGNOSTIC ERROR; EVALUATION STUDY; FLUORESCENCE IMAGING; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMAN; ISOLATION AND PURIFICATION; LABORATORY AUTOMATION; MASS SCREENING; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PROCEDURES;

CHROMOGENIC SUBSTRATE; CULTURE MEDIUM;

AUTOMATION, LABORATORY; BACTERIOLOGICAL TECHNIQUES; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; DIAGNOSTIC ERRORS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MASS SCREENING; OPTICAL IMAGING; SENSITIVITY AND SPECIFICITY; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84991216241     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01040-16     Document Type: Article

References (23)

1. Bouza E, Kestler M, Beca T, Mariscal G, Rodríguez-Créixems M, Bermejo J, Fernández-Cruz A, Fernández-Avilés F, Muñoz P; Grupo de Apoyo al Manejo de la Endocarditis. 2015. The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. Clin Infect Dis 60:528-535. http://dx.doi.org/10.1093/cid/ciu872.
2. Garrison RN, Fry DE, Berberich S, Polk HC, Jr. 1982. Enterococcal bacteremia: clinical implications and determinants of death. Ann Surg 196:43-47. http://dx.doi.org/10.1097/00000658-198207000-00010.
3. Wang QY, Li RH, Shang XH. 2015. Urinary tract infection caused by Enterococcus isolates: aetiology and antimicrobial resistance patterns. J Chemother 27:117-119. http://dx.doi.org/10.1179/1973947814Y.0000000192.
4. O'Driscoll T, Crank CW. 2015. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infection and drug resistance 8:217-230.
5. Murray BE. 1990. The life and times of the Enterococcus. Clin Microbiol Rev 3:46-65. http://dx.doi.org/10.1128/CMR.3.1.46.
6. Uttley AH, Collins CH, Naidoo J, George RC. 1988. Vancomycin-resistant enterococci. Lancet i:57-58.
7. Arthur M, Depardieu F, Gerbaud G, Galimand M, Leclercq R, Courvalin P. 1997. The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction. J Bacteriol 179:97-106.
8. Arthur M, Molinas C, Depardieu F, Courvalin P. 1993. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 175:117-127.
9. Kramer A, Schwebke I, Kampf G. 2006. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130. http://dx.doi.org/10.1186/1471-2334-6-130.
10. Noskin GA, Siddiqui F, Stosor V, Kruzynski J, Peterson LR. 1999. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin. Clin Infect Dis 28:689-690. .
11. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. 2005. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41:327-333. http://dx.doi.org/10.1086/430909.
12. Perencevich EN, Fisman DN, Lipsitch M, Harris AD, Morris JG, Jr, Smith DL. 2004. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units. Clin Infect Dis 38:1108-1115. http://dx.doi.org/10.1086/382886.
13. Faron ML, Buchan BW, Vismara C, Lacchini C, Bielli A, Gesu G, Liebregts T, van Bree A, Jansz A, Soucy G, Korver J, Ledeboer NA. 30 December 2015. Automated scoring of chromogenic media for the detection of MRSA using the WASPLab image analysis software. J Clin Microbiol http://dx.doi.org/10.1128/JCM.02778-15.
14. Julious SA. 2005. Two-sided confidence intervals for the single proportion: comparison of seven methods by Robert G. Newcombe, Statistics in Medicine 1998; 17:857-872. Stat Med 24:3383-3384.
15. McNemar Q. 1947. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12:153-157. http://dx.doi.org/10.1007/BF02295996.
16. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A, Limbago B, Fridkin S; National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities. 2013. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34:1-14. http://dx.doi.org/10.1086/668770.
17. Werner G, Coque TM, Hammerum AM, Hope R, Hryniewicz W, Johnson A, Klare I, Kristinsson KG, Leclercq R, Lester CH, Lillie M, Novais C, Olsson-Liljequist B, Peixe LV, Sadowy E, Simonsen GS, Top J, Vuopio-Varkila J, Willems RJ, Witte W, Woodford N. 2008. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill 13(47):pii=19046. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19046.
18. Ostrowsky BE, Trick WE, Sohn AH, Quirk SB, Holt S, Carson LA, Hill BC, Arduino MJ, Kuehnert MJ, Jarvis WR. 2001. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 344:1427-1433. http://dx.doi.org/10.1056/NEJM200105103441903.
19. Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. 2007. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 35(Suppl 2):S165-S193. http://dx.doi.org/10.1016/j.ajic.2007.10.006.
20. Shadel BN, Puzniak LA, Gillespie KN, Lawrence SJ, Kollef M, Mundy LM. 2006. Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications. Infect Control Hosp Epidemiol 27:1068-1075. http://dx.doi.org/10.1086/507960.
21. Jenkins SG, Raskoshina L, Schuetz AN. 2011. Comparison of performance of the novel chromogenic spectra VRE agar to that of bile esculin azide and Campylobacter agars for detection of vancomycin-resistant enterococci in fecal samples. J Clin Microbiol 49:3947-3949. http://dx.doi.org/10.1128/JCM.00180-11.
22. Suwantarat N, Roberts A, Prestridge J, Seeley R, Speser S, Harmon C, Zhang C, Henciak S, Stamper PD, Ross T, Carroll KC. 2014. Comparison of five chromogenic media for recovery of vancomycin-resistant enterococci from fecal samples. J Clin Microbiol 52:4039-4042. http://dx.doi.org/10.1128/JCM.00151-14.
23. Valdezate S, Miranda C, Navarro A, Freitas AR, Cabrera JJ, Carrasco G, Coque TM, Jimenez-Romano E, Saez-Nieto JA. 2012. Clonal outbreak of ST17 multidrug-resistant Enterococcus faecium harbouring an Inc18-like::Tn1546 plasmid in a haemo-oncology ward of a Spanish hospital. J Antimicrob Chemother 67:832-836. http://dx.doi.org/10.1093/jac/dkr545.